Johnson & Johnson vs. vTv Therapeutics Inc. Class A Common Stock
JNJ
Johnson & Johnson
$260.35 -0.66%
VS VTVTvTv Therapeutics Inc. Class A Common Stock
$30.12 -2.37%
Johnson & Johnson (JNJ) comes out ahead, leading on 6 of 8 compared factors.
Size & Scale
| JNJ | VTVT | |
|---|---|---|
| Market Cap | $627.42 billion | $119.09 million |
| Revenue (TTM) | $97.93 billion | $36.84 million |
| Net Income (TTM) | $21.04 billion | $-6,403,000 |
JNJ leads on 3 of 3 size & scale factors.
Valuation
| JNJ | VTVT | |
|---|---|---|
| P/E Ratio | 30.20 | — |
| Price / Book | 7.38 | 1.51 |
| Price / Sales | 6.41 | 3.23 |
VTVT leads on 2 of 2 valuation factors.
Profitability
| JNJ | VTVT | |
|---|---|---|
| Net Margin | 21.48% | -17.38% |
| Return on Equity | 24.76% | -8.14% |
JNJ leads on 2 of 2 profitability factors.
Dividend
| JNJ | VTVT | |
|---|---|---|
| Dividend Yield | 2.06% | — |
| Payout Ratio | 62.18 | — |
JNJ and VTVT split the dividend factors evenly.
Risk & Sentiment
| JNJ | VTVT | |
|---|---|---|
| Short Interest | 0.67% | 10.46% |
JNJ leads on 1 of 1 risk & sentiment factors.
Dig deeper: JNJ overview, JNJ financials, VTVT overview, VTVT financials.
Comparisons use delayed, cached fundamental data and cover only the factors shown. For informational purposes only — not investment advice.